Tools4Patient Raises Series B Financing for Commercial Expansion of Clinical Development Solutions
Placebell©™ technology designed to limit the negative impact of the placebo effect in clinical trials.
News
News
News
Opportunities Available for Collaboration
While drug developers have been struggling with the placebo response for decades, Placebell©™ is the first commercially available technology that enables scientists to control for the placebo response in clinical studies. Tools4Patient (T4P) launched Placebell©™ in late 2017,
News
Tools4Patient Strengthens Group’s Expertise with North American Business Development Team
The commercial launch of Placebell©™ for peripheral neuropathic pain in October 2017 has increased interest from biopharma industry stakeholders in T4P’s low-risk validated technology.
News
T4P Announces Initial Study to Validate Placebell©™ in Parkinson’s Disease
Following the commercial launch of Placebell©™ in peripheral neuropathic pain in October 2017 and the initiation of the validation of Placebell©™ in osteoarthritis in August 2017,